R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 25

Key Points

• This update explores the integration of real-world data in health technology assessments, focusing on economic evaluations and regulatory approvals.
• Reviewed recent developments in real-world evidence and its impact on health assessments.
• Analyzed economic evaluations by Haute Autorité de Santé using real-world data.
• Considered outcomes from the semaglutide EVOKE trials in Alzheimer's disease for target trial emulation.
• Real-world data enhances economic evaluations, informing healthcare decision-making.
• Support for regulatory approvals in multiple myeloma based on real-world evidence was noted.
• Lessons learned from the EVOKE trials highlight challenges in applying target trial emulation.